Recent Publications

Supreme Court Overturns the Chevron Doctrine – Potential Impacts on Healthcare Providers and Pharmacies – Part 2

On June 28, 2024, the US Supreme Court overturned the Chevron Doctrine in the landmark decision Loper Bright Enterprises et al. v. Raimondo. This ruling marks a significant shift in how federal courts will review federal agency interpretations of laws.

In a new article, Frier Levitt attorneys Todd Mizeski, A.J. Barbarito and Nicholas Batlle examine the Court’s decision, their reasoning, and specific implications for entities in the healthcare and life sciences space. Read here.

Additionally, read Part 1, "Supreme Court Revisits the Chevron Doctrine – Potential Impacts on Healthcare Providers and Pharmacies" here.

Securing Favorable Outcomes in Payor Disputes Through Early Intervention

In an insightful article, Frier Levitt partner Guillermo Beades discusses how early legal intervention can help secure favorable outcomes when facing payor challenges.

This article comes following the Healthcare Leaders Association of New Jersey (HLA NJ) Annual Conference, that took place on June 5th - 8th, where our attorneys spoke on defending against payor audits.

Read the article to learn more here.

Compounding Semaglutide – What Stakeholders Need To Know

Due to supply shortages and gaps in insurance coverage, GLP-1 medications are increasingly ordered and compounded through innovative business models involving telehealth, cash-only arrangements, subscription payments, and various fulfillment methods. Developing these models requires addressing critical regulatory issues.

Frier Levitt attorneys Arielle Miliambro and Christopher Maniscalco provide an in depth article on navigating these challenges here.

Civility and Communication: Managing Disruptive Physicians and Addressing Harassment Complaints – Hospital & Physician Webinar Series Summary

Frier Levitt partners Todd Brower and Alex Keoskey recently presented Part 2 of our 3-part webinar series, “Exploring Hospital and Physician Dynamics: A Primer on Medical Staff Adverse Actions.” See webinar section below.

For an overview of what was discussed in Part 2, titled “Civility and Communication: Managing Disruptive Physicians and Addressing Harassment Complaints,” read the article by attorney Phoebe A. Nelson here.

The Essential Role of Legal Counsel in Home Care and Hospice Audits

Home care and hospice providers are increasingly subjected to audits from payors, focusing on billing and coding compliance. These audits can lead to significant financial and legal risks if not handled properly.

Frier Levitt partner Guillermo Beades discusses these audits in a new article, explaining the risks of inadequate responses, the importance of early legal intervention, and proactive measures for home care and hospice providers.

Read here.

On-Demand Webinar Series

Exploring Hospital and Physician Dynamics:

A Primer on Medical Staff Adverse Actions

Frier Levitt partners Todd Brower and Alex Keoskey present “Exploring Hospital and Physician Dynamics: A Primer on Medical Staff Adverse Actions,” a 3-part webinar series designed for physicians, in-house counsel, corporate leaders, attorneys, and regulatory investigators that deal with hospital and healthcare systems. This series offers valuable insights into adverse actions in healthcare settings.

Click the images below to view each webinar:

Part 1, “Understanding the Disciplinary Process: Hospital Bylaws, Reporting Adverse Actions, and Legal Considerations.”

Part 2, "Civility and Communication: Managing Disruptive Physicians and Addressing Harassment Complaints"  

Part 3, "Adverse Action Reporting: The Consequences of a Permanent Record" 

Client Triumphs

Frier Levitt Secures Landmark $22M+ Trial Victory Against Caremark, Recovering 100% of DIR Fees, Interest, and Attorney Fees

Frier Levitt Secures Reversal of Medicare Revocation of a Provider’s Medicare Enrollment and Billing Privileges

Frier Levitt Successfully Reduces Multiple Overpayment Demands for Three Different Practices

Industry Insights

Frier Levitt Cited Three Times in House Committee Report on Pharmacy Benefit Managers “The Role of Pharmacy Benefit Managers in Prescription Drug Markets”

Daniel Frier Quoted in Axios “The FTC Hones in on Dialysis Noncompetes”

Alex Keoskey Published in Medical Economics “Getting It Right the First Time: The Importance of Thorough Medical Credentialing”

Guillermo Beades Published in New Jersey Pediatrics – Summer 2024 Issue by NJAAP "Drawing a Line in the Sand with Payors"

Lawrence Kobak Published in Podiatry Management “The ADA – Some Lesser-Known Wrinkles”

Brandon Zarsky Published in Medical Economics “Medical Aesthetic Services: A Host of Opportunities and Legal Uncertainties”

Frier Levitt’s Government Investigations, Litigation & White-Collar Defense Group is comprised of seasoned professionals, including a former Assistant United States Attorney, Deputy Attorneys General, and healthcare litigators who have decades of experience defending corporate entities, executives, and healthcare and life sciences professionals for alleged healthcare violations.

Our attorneys bring a wealth of firsthand knowledge of how government agencies conduct investigations and prosecute cases. This litigation-centric experience and skillset, combined with the firm’s extensive regulatory, transactional, and clinical knowledge, work to resolve such cases successfully, often doing so before public charges are filed.

Contact Frier Levitt to speak to an attorney about regulatory concerns, government inquiries, subpoena and CID defense, as well as litigation defense.

Learn more about Frier Levitt's Government Investigations, Litigation & White-Collar Defense here.

Very truly yours,

Daniel B. Frier, Esq.

Co-Founding Partner

Frier Levitt

dbfrier@frierlevitt.com

973.618.1660

Bio | LinkedIn